Pera Antonio R 4

What Happened

Antonio R. Pera, a director of ANI Pharmaceuticals (ANIP), received a restricted stock award of 4,357 shares on May 21, 2026. The Form 4 reports the acquisition at $0.00 (award/grant), so no cash payment was made at grant; the filing was submitted June 10, 2026.

Key Details

• Transaction date: May 21, 2026; reported on Form 4 filed June 10, 2026.
• Transaction type/price: Award (code A) — 4,357 shares at $0.00 (acquired).
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: The award is a restricted stock award that vests in full on May 21, 2027.
• Timeliness: Filing was made ~20 days after the transaction date; Form 4s are typically required within two business days, so this appears late.

Context

Restricted stock awards are a form of compensation and typically vest over time (here, fully on May 21, 2027). Such grants reflect company compensation practices rather than an immediate buy or sell signal; until vested, the shares are usually subject to forfeiture or transfer restrictions.